EROSIVE AND ULCERATIVE LESIONS OF THE GASTRODUODENAL ZONE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Keywords:
rheumatoid arthritis, gastroduodenal lesion, prognosis.Abstract
Lesions of the gastroduodenal mucosa in patients with rheumatic diseases are widespread and have a significant impact on the course, prognosis, and treatment of the underlying disease. Factors that negatively affect the condition of the gastric and duodenal mucosa in rheumatic diseases, in particular rheumatoid arthritis, include inflammation of the mucous membrane of the digestive tract, vasculitis, and taking nonsteroidal anti-inflammatory drugs (NSAIDs)., concomitant diseases of the digestive tract, the manifestations or exacerbations of which are caused by the course of rheumatic diseases and the use of NSAIDs. The connection of lesions with reception has been revealed. NSAIDs, the severity of their occurrence, localization in the antrum of the stomach, the absence of an inflammatory shaft around the ulcerative defect, such a histological feature as foveolar hyperplasia of the mucous membrane, and sufficiently rapid healing after NSAID withdrawal.
References
1.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRIT KASALLIGIDA METABOLIK REGULYASIYA. Научный Фокус, 2(19), 429-434.
2.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRITDA STEROID DIABET OLDINI OLISH. Научный Фокус, 2(19), 425-428.
3.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRIT KASALLIGIDA METORTRIT VA NOSTEROIDLARNI BIRGA QOLLASHDA TERAPEVTIK SAMARADORLIK. Научный Фокус, 2(19), 418-424.
4.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). TIZIMLI QIZIL YUGURIK KASALLIGI. Научный Фокус, 2(19), 413-417.
5.Uralov, R. S., Omonov, S. A., & Zaripov, J. S. SOME INDICATORS OF THE HEMOSTASIS SYSTEM IN THROMBOCYTOPENIA OF DRUG AND NON-DRUG GENESIS IN THE CLINIC INTERNAL DISEASES. УЧЕНЫЙ XXI ВЕКА, 28(10), 79-88.
6.Тоиров, Э., Исломова, К., & Уралов, Р. (2019). Эффективность комплексного лечения раннего остеоартроза. Журнал вестник врача, 1(3), 99-103.
7.Gazkhanovna, M. A., Khaidarovna, M. F., & Ugli, U. R. S. (2020). Clinical And Electro-Neuromyographic Changes In The Pathology Of The Muscular System In Patients With Hemophilia. The American Journal of Medical Sciences and Pharmaceutical Research, 2(11), 53-56.
8.Абдушукурова, К. Р., Исламова, К. А., Хамраева, Н. А., & Уралов, Р. Ш. (2023). ФФЕКТИВНОСТЬ ЛЕЧЕНИЯ РЕВМАТОИДНОГО АРТРИТА. IQRO, 2(2), 194-200.
9.Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., & Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-control Study. International journal of health sciences, 6(S10), 175-182.
10.Авазова, Т. А., & Хаитова, Н. М. (2011). ЭФФЕКТИВНОСТЬ ПРИМЕНЕНИЯ ПРЕПАРАТА" TAF" ЛАКТОФЛОР У БОЛЬНЫХ МЕТАБОЛИЧЕСКИМ СИНДРОМОМ. Врач-аспирант, 49(6.1), 209-212.
11.Авазова, T. (2012). Метаболический синдром (обзор литературы). Журнал вестник врача, 1(3), 217-219.
12.Ismailova, A. A., Uralova, S. A., Nigmatova, L. M., Adylov, D. G., Petrova, T. A., Nabieva, U. P., & Avazova, T. A. (2017). The optimization of technique of detection of cryoglobulins in conditions of clinical diagnostic laboratory. Klinicheskaia Laboratornaia Diagnostika, 62(1), 50-52.
13.Avazova, T., Khaitova, N., & Ismailova, A. (2013). Significance of IL-6 and IL-17 cytokines in diagnostics and prognosis of the metabolic syndrome. Medical and Health Science Journal, 14(1), 40-45.
14.Avazova, T., & Rogelio, P. (2024). Effects of Ursodeoxycholic Acid on Inflammatory Markers IL-6 and IL-17 in Patients with Metabolic Syndrome. Frontiers of Global Science, 2(1), 12-16.
15.Ibragimov, K., Sultonov, I., & Ravshanova, M. (2024). The Effectiveness of the Combination Therapy with biologic DMARDS in Rheumatoid Arthritis. Frontiers of Global Science, 2(1), 17-24.
